A Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (Wilate)

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2010年 / 52卷 / 1340期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [1] Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/ factor VIII concentrate
    Iorio, Alfonso
    James, Paula
    Ma, Alice
    Srivastava, Alok
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (10) : 2739 - 2744
  • [2] von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
    Sidonio Jr, Robert F.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Boda, Zoltan
    Lissitchkov, Toshko
    Nemes, Laszlo
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia Djambas
    BLOOD ADVANCES, 2024, 8 (06) : 1405 - 1414
  • [3] A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease
    Rugeri, Lucia
    Thomas, Will
    Schirner, Kathrin
    Heyder, Lisa
    Auerswald, Guenter
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (09) : 828 - 841
  • [4] Accumulation of factor VIII and von Willebrand factor during prophylaxis with a plasma-derived von Willebrand FACTOR/FACTOR VIII concentrate during the WIL-31 study
    Kateryna, V. V.
    Vdovin, V.
    Timofeeva, M. A.
    Khayat, C. D.
    Inati, A.
    Sidonio, R. F., Jr.
    HAEMOPHILIA, 2024, 30 : 139 - 140
  • [5] Efficacy and safety of plasma-derived von Willebrand factor/ factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysis
    Sidonio Jr, Robert F.
    Dubey, Leonid
    Vilchevska, Kateryna V.
    Inati, Adlette
    Khayat, Claudia Djambas
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2025, 9 (02)
  • [6] Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update
    Ettingshausen, Carmen Escuriola
    Lassila, Riitta
    Escolar, Gines
    Male, Christoph
    Schirner, Kathrin
    Heyder, Lisa
    Berntorp, Erik
    HAEMOPHILIA, 2025, 31 (02) : 247 - 262
  • [7] Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/ Factor VIII Concentrate in Previously Treated Patients with Von Willebrand Disease
    Sidonio, Robert F., Jr.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Lissitchkov, Toshko
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia
    BLOOD, 2022, 140 : 8438 - 8439
  • [8] Effect of Factor VIII and Von Willebrand Factor Activities on Number of Bleeding Events in Previously Treated Patients with Von Willebrand Disease on Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Timofeeva, Margarita
    Khayat, Claudia Djambas
    Inati, Adlette
    Robert, Sidonio F., Jr.
    BLOOD, 2023, 142
  • [9] Recombinant Von Willebrand factor concentrate in 2A Von Willebrand disease: comparison to plasma-derived Von Willebrand factor concentrate therapy
    Rajpurkar, Madhvi
    Frey, Mary Jane
    Sabo, Cynthia
    Hollon, Wendy
    BLOOD COAGULATION & FIBRINOLYSIS, 2019, 30 (04) : 168 - 170
  • [10] Regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate is effective for reducing nosebleeds in children and adults with von Willebrand disease
    Boban, A.
    Sidonio, R. F., Jr.
    Dubey, L.
    Vilchevska, K.
    Inati, A.
    Khayat, C. D.
    HAEMOPHILIA, 2024, 30 : 20 - 20
12345